valine has been researched along with Desmoid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcindor, T; Attia, S; Bailey, HH; Benson, C; Bui, NQ; Burgess, MA; Charlson, J; Chawla, S; Chugh, R; Cote, GM; D'Amato, G; Davis, LE; Deshpande, H; Dileo, P; Federman, N; Gelderblom, H; Gounder, M; Grignani, G; Hartner, L; Kasper, B; Kummar, S; Lapeire, L; Lim, A; Loggers, E; Mazzeo, F; Merriam, P; Moody, S; Palmerini, E; Philip, T; Pressey, JG; Ratan, R; Reichardt, P; Riedel, RF; Schöffski, P; Smith, LM; Stacchiotti, S; Tinoco, G; van der Graaf, WT; Van Tine, BA; Vincenzi, B; Wilky, BA | 1 |
| Sidaway, P | 1 |
| Janeway, KA; Prensner, JR; Robson, CD; Takahashi, T; Weigel, BJ | 1 |
| Chen, AP; Choudhary, A; Choyke, PL; Do, KT; Doroshow, JH; Helman, LJ; Horneffer, Y; Juwara, L; Kummar, S; Lih, A; Meehan, R; Meltzer, PS; Mitchell, SA; O'Sullivan Coyne, G; Polley, E; Turkbey, B; Vilimas, R | 1 |
| Blatchford, PJ; Cesari, R; Elias, A; Gore, L; Hall, F; Hoffner, B; Huang, B; Jimeno, A; Kern, K; Messersmith, W; Schowinsky, JT; Villalobos, VM | 1 |
| Al Sannaa, GA; Bolshakov, S; Braggio, D; Creighton, CJ; Lazar, AJ; Lee, YJ; Lev, D; Pollock, RE; Shang, H | 1 |
3 trial(s) available for valine and Desmoid
| Article | Year |
|---|---|
Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.
Topics: Adult; Amyloid Precursor Protein Secretases; Antineoplastic Agents; Double-Blind Method; Female; Fibromatosis, Aggressive; Gamma Secretase Inhibitors and Modulators; Humans; Progression-Free Survival; Quality of Life; Tetrahydronaphthalenes; Valine | 2023 |
Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis).
Topics: Adenomatous Polyposis Coli Protein; Adult; Aged; Amyloid Precursor Protein Secretases; Antineoplastic Agents; beta Catenin; Female; Fibromatosis, Aggressive; Genotype; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Patient Reported Outcome Measures; Response Evaluation Criteria in Solid Tumors; Retreatment; Symptom Assessment; Tetrahydronaphthalenes; Tomography, X-Ray Computed; Valine; Young Adult | 2017 |
Long-Term Follow-Up of Desmoid Fibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor.
Topics: Administration, Oral; Amyloid Precursor Protein Secretases; Fibromatosis, Aggressive; Follow-Up Studies; Humans; Prognosis; Retrospective Studies; Tetrahydronaphthalenes; Time Factors; Valine | 2018 |
3 other study(ies) available for valine and Desmoid
| Article | Year |
|---|---|
Nirogacestat effective in desmoid tumours.
Topics: Fibromatosis, Aggressive; Humans; Tetrahydronaphthalenes; Valine | 2023 |
Safety and efficacy of gamma-secretase inhibitor nirogacestat (PF-03084014) in desmoid tumor: Report of four pediatric/young adult cases.
Topics: Adolescent; Adult; Amyloid Precursor Protein Secretases; Child, Preschool; Female; Fibromatosis, Aggressive; Humans; Male; Prognosis; Safety; Tetrahydronaphthalenes; Valine; Young Adult | 2020 |
Targeting the Notch pathway: A potential therapeutic approach for desmoid tumors.
Topics: CCN Intercellular Signaling Proteins; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Fibromatosis, Aggressive; Humans; Neoplasm Invasiveness; Receptors, Notch; Repressor Proteins; Signal Transduction; Tetrahydronaphthalenes; Valine | 2015 |